LFCR · Categories · Form 4

LFCR - SEC Form 4 insider transactions

Lifecore Biomedical Inc. (LFCR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for LFCR

• 1d
  Director Kiper Christopher S was granted 25,907 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 4d
  Director Obus Nelson was granted 25,907 shares, increasing direct ownership by 19% to 164,100 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 4d
  Director Aryeh Jason was granted 25,907 shares, increasing direct ownership by 59% to 69,967 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 4d
  Director Korenberg Matthew E was granted 25,907 shares, increasing direct ownership by 59% to 69,967 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 4d
  Director Schechter Joshua was granted 25,907 shares, increasing direct ownership by 24% to 133,080 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 4d
  Director Antunes Humberto Calheiros was granted 25,907 shares, increasing direct ownership by 55% to 72,967 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 4d
  Director Johnson Paul Harold was granted 25,907 shares, increasing direct ownership by 59% to 69,967 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 4d
  Director Houde Lovas Katrina was granted 25,907 shares, increasing direct ownership by 24% to 135,319 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 19d
  Chief Executive Officer Josephs Paul covered exercise/tax liability with 40,413 shares, decreasing direct ownership by 6% to 592,915 units (SEC Form 4) (withholding tax)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 54d
  SEC Form 4 filed by Salus Thomas D.

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 98d
  Chief Legal & Administration Salus Thomas D. was granted 30,000 shares, increasing direct ownership by 12% to 270,978 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 278d
  Chief Financial Officer Lake Ryan David covered exercise/tax liability with 22,932 shares, decreasing direct ownership by 6% to 336,691 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 327d
  Director Obus Nelson was granted 19,506 shares, increasing direct ownership by 16% to 138,193 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 327d
  Director Kiper Christopher S was granted 19,506 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 327d
  Director Johnson Paul Harold was granted 19,506 shares, increasing direct ownership by 79% to 44,060 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 327d
  Director Aryeh Jason was granted 19,506 shares, increasing direct ownership by 79% to 44,060 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 327d
  Director Korenberg Matthew E was granted 19,506 shares, increasing direct ownership by 79% to 44,060 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 327d
  Director Antunes Humberto Calheiros was granted 19,506 shares, increasing direct ownership by 71% to 47,060 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 327d
  Director Schechter Joshua was granted 19,506 shares, increasing direct ownership by 22% to 107,173 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 327d
  Director Houde Lovas Katrina was granted 19,506 shares, increasing direct ownership by 22% to 109,412 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 334d
  Chief Legal & Administration Salus Thomas D. converted options into 37,000 shares and covered exercise/tax liability with 11,022 shares, increasing direct ownership by 12% to 240,978 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 334d
  Chief Financial Officer Lake Ryan David converted options into 75,000 shares and covered exercise/tax liability with 32,806 shares, increasing direct ownership by 13% to 359,623 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 334d
  Chief Executive Officer Josephs Paul converted options into 150,000 shares and covered exercise/tax liability with 54,857 shares, increasing direct ownership by 18% to 633,328 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 376d
  Large owner English Aron R. sold $9,132,503 worth of shares (1,386,060 units at $6.59) (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 383d
  Chief Executive Officer Josephs Paul covered exercise/tax liability with 21,532 shares, decreasing direct ownership by 4% to 538,185 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 389d
  Large owner English Aron R. sold $86,353 worth of shares (12,334 units at $7.00) (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 393d
  Large owner English Aron R. sold $362,019 worth of shares (51,496 units at $7.03) (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 397d
  Large owner English Aron R. sold $289,869 worth of shares (41,091 units at $7.05) (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 419d
  Chief Legal & Administration Salus Thomas D. was granted 215,000 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 546d
  Chief Executive Officer Josephs Paul covered exercise/tax liability with 11,769 shares and was granted 38,461 shares, increasing direct ownership by 5% to 542,717 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 546d
  Chief Financial Officer Lake Ryan David was granted 19,720 shares and covered exercise/tax liability with 5,653 shares, increasing direct ownership by 5% to 317,429 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 588d
  Chief Financial Officer Lake Ryan David converted options into 75,000 shares and covered exercise/tax liability with 34,138 shares, increasing direct ownership by 16% to 303,362 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 631d
  Amendment: Director Antunes Humberto Calheiros was granted 24,554 shares, increasing direct ownership by 818% to 27,554 units (SEC Form 4)

  4/A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 642d
  Chief Financial Officer Lake Ryan David was granted 262,500 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 656d
  Director Johnson Paul Harold was granted 24,554 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 656d
  Director Antunes Humberto Calheiros was granted 24,554 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 656d
  Director Aryeh Jason was granted 24,554 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 656d
  Director Korenberg Matthew E was granted 24,554 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 698d
  Director Barbarosh Craig A. was granted 30,000 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 698d
  Director Calloway Nathaniel was granted 30,000 shares, increasing direct ownership by 107% to 58,069 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 698d
  Director Diradoorian Raymond H was granted 30,000 shares, increasing direct ownership by 75% to 69,978 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 699d
  Director Edwards Jeffrey L was granted 30,000 shares, increasing direct ownership by 60% to 79,667 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 699d
  Director Houde Lovas Katrina was granted 30,000 shares, increasing direct ownership by 50% to 89,906 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 699d
  Director Obus Nelson was granted 30,000 shares, increasing direct ownership by 34% to 118,687 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 699d
  Director Schechter Joshua was granted 30,000 shares, increasing direct ownership by 52% to 87,667 units (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 699d
  Director Kiper Christopher S was granted 30,000 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)
• 748d
  Josephs Paul was granted 525,000 shares and covered exercise/tax liability with 8,975 shares (SEC Form 4)

  4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)

Other LFCR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends